Vertex Pharmaceuticals - 29 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits. The latest closing stock price for Vertex Pharmaceuticals as of September 18, 2020 is 265.39.
  • The all-time high Vertex Pharmaceuticals stock closing price was 303.10 on July 20, 2020.
  • The Vertex Pharmaceuticals 52-week high stock price is 306.08, which is 15.3% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 165.23, which is 37.7% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 242.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 258.6866 219.4500 303.1000 199.7700 265.3900 21.21%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $69.125B $4.163B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.088B 15.76
Bristol Myers Squibb (BMY) United States $134.110B 10.33
CSL (CSLLY) Australia $93.803B 0.00
Gilead Sciences (GILD) United States $81.555B 11.74
Regeneron Pharmaceuticals (REGN) United States $59.073B 22.59
Biogen (BIIB) United States $43.454B 7.44
Illumina (ILMN) United States $43.143B 50.17
Seattle Genetics (SGEN) United States $31.483B 0.00
Moderna (MRNA) United States $27.570B 0.00
Genmab (GMAB) Denmark $25.300B 15.98
Alexion Pharmaceuticals (ALXN) United States $24.924B 10.39
BeiGene (BGNE) Cayman Islands $24.668B 0.00
Genmab (GNMSF) Denmark $23.997B 5.53
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Immunomedics (IMMU) United States $19.770B 0.00
Incyte (INCY) United States $18.981B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.502B 38.61
Alnylam Pharmaceuticals (ALNY) United States $15.338B 0.00
BioNTech SE (BNTX) Germany $15.160B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.059B 68.11
BioMarin Pharmaceutical (BMRN) United States $14.396B 104.45
ARGENX SE-ADR (ARGX) Netherlands $11.740B 0.00
Exact Sciences (EXAS) United States $11.633B 0.00
QIAGEN (QGEN) Netherlands $11.522B 29.24
Sarepta Therapeutics (SRPT) United States $11.346B 0.00
Guardant Health (GH) United States $10.191B 0.00
Bio-Techne Corp (TECH) United States $9.404B 64.52
Galapagos (GLPG) Belgium $9.087B 32.92
Exelixis (EXEL) United States $8.281B 30.11
SWEDISH ORP BIO (BIOVF) Sweden $7.799B 19.40
Ascendis Pharma (ASND) Denmark $7.768B 0.00
Repligen (RGEN) United States $7.665B 121.66
MyoKardia (MYOK) United States $7.238B 0.00
Mirati Therapeutics (MRTX) United States $7.175B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.689B 0.00
Novavax (NVAX) United States $6.640B 0.00
Acceleron Pharma (XLRN) United States $6.383B 0.00
Adaptive Biotechnologies (ADPT) United States $6.294B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.220B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.028B 186.74
Emergent Biosolutions (EBS) United States $5.324B 21.09
Ultragenyx Pharmaceutical (RARE) United States $5.021B 0.00
MorphoSys AG (MOR) Germany $4.503B 59.02
China Biologic Products (CBPO) China $4.408B 26.16
Blueprint Medicines (BPMC) United States $4.391B 0.00
Vir Biotechnology (VIR) United States $4.157B 0.00
Legend Biotech (LEGN) United States $4.136B 0.00
Arena Pharmaceuticals (ARNA) United States $4.107B 0.00
Denali Therapeutics (DNLI) United States $4.092B 0.00
NeoGenomics (NEO) United States $3.957B 1194.33
Halozyme Therapeutics (HALO) United States $3.801B 0.00
Amicus Therapeutics (FOLD) United States $3.778B 0.00
Bluebird Bio (BLUE) United States $3.752B 0.00
Reata Pharmaceuticals (RETA) United States $3.545B 0.00
Fate Therapeutics (FATE) United States $3.409B 0.00
Global Blood Therapeutics (GBT) United States $3.395B 0.00
Insmed (INSM) United States $3.386B 0.00
Principia Biopharma (PRNB) United States $3.330B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.161B 0.00
Twist Bioscience (TWST) United States $3.029B 0.00
Alkermes (ALKS) Ireland $2.868B 60.10
Inovio Pharmaceuticals (INO) United States $2.848B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
Sorrento Therapeutics (SRNE) United States $2.282B 0.00
Intra-Cellular Therapies (ITCI) United States $2.117B 0.00
Editas Medicine (EDIT) United States $2.111B 0.00
Revance Therapeutics (RVNC) United States $2.106B 0.00
I-Mab (IMAB) China $2.092B 0.00
Mesoblast (MESO) Australia $2.092B 0.00
Zymeworks (ZYME) Canada $2.069B 0.00
Eidos Therapeutics (EIDX) United States $2.034B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Seres Therapeutics (MCRB) United States $1.956B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.862B 0.00
UniQure (QURE) Netherlands $1.853B 0.00
Akcea Therapeutics (AKCA) United States $1.844B 0.00
Viela Bio (VIE) United States $1.628B 0.00
Amarin (AMRN) Ireland $1.607B 0.00
Cytokineticsorporated (CYTK) United States $1.537B 0.00
Sangamo Therapeutics (SGMO) United States $1.525B 0.00
Beam Therapeutics (BEAM) United States $1.524B 0.00
Mersana Therapeutics (MRSN) United States $1.509B 0.00
Ligand Pharmaceuticals (LGND) United States $1.480B 50.04
Dicerna Pharmaceuticals (DRNA) United States $1.478B 0.00
Zealand Pharma (ZEAL) Denmark $1.451B 0.00
Arcus Biosciences (RCUS) United States $1.424B 0.00
Coherus BioSciences (CHRS) United States $1.422B 8.29
Intercept Pharmaceuticals (ICPT) United States $1.382B 0.00
Intellia Therapeutics (NTLA) United States $1.381B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.357B 0.00
Epizyme (EPZM) United States $1.346B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
NGM Biopharmaceuticals (NGM) United States $1.317B 0.00
Compugen (CGEN) Israel $1.290B 0.00
Alcobra (ARCT) United States $1.144B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.137B 0.00
REGENXBIO (RGNX) United States $1.118B 0.00
Alector (ALEC) United States $1.115B 0.00
Arvinas (ARVN) United States $1.098B 0.00
Athenex (ATNX) United States $1.073B 0.00
Retrophin (RTRX) United States $1.031B 0.00
Castle Biosciences (CSTL) United States $1.005B 0.00
Pliant Therapeutics (PLRX) United States $1.000B 0.00
Adverum Biotechnologies (ADVM) United States $0.999B 0.00
Myriad Genetics (MYGN) United States $0.966B 0.00
Agenus (AGEN) United States $0.950B 0.00
Heska (HSKA) United States $0.933B 0.00
NantKwest (NK) United States $0.917B 0.00
Morphic Holding (MORF) United States $0.885B 0.00
Cellectis S.A (CLLS) France $0.885B 0.00
Vericel (VCEL) United States $0.865B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.842B 0.00
Frequency Therapeutics (FREQ) United States $0.840B 0.00
VBI Vaccines (VBIV) United States $0.828B 0.00
Intrexon (PGEN) United States $0.810B 0.00
Protagonist Therapeutics (PTGX) United States $0.810B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Codexis (CDXS) United States $0.720B 0.00
MiMedx (MDXG) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
WAVE Life Sciences (WVE) Singapore $0.712B 0.00
Cara Therapeutics (CARA) United States $0.681B 0.00
Northwest Biotherapeutics (NWBO) United States $0.669B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.656B 0.00
AC Immune SA (ACIU) Switzerland $0.644B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Clovis Oncology (CLVS) United States $0.614B 0.00
Geron (GERN) United States $0.609B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Dynavax Technologies (DVAX) United States $0.595B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.591B 0.00
Albireo Pharma (ALBO) United States $0.583B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.580B 0.00
IVERIC Bio (ISEE) United States $0.563B 0.00
Forte Biosciences (FBRX) United States $0.555B 0.00
Cel-Sci (CVM) United States $0.554B 0.00
Kala Pharmaceuticals (KALA) United States $0.551B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.538B 4.71
Anika Therapeutics (ANIK) United States $0.519B 22.70
Cue Biopharma (CUE) United States $0.510B 0.00
Celldex Therapeutics (CLDX) United States $0.506B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.503B 0.00
MannKind (MNKD) United States $0.477B 0.00
UROGEN PHARMA (URGN) United States $0.470B 0.00
Syros Pharmaceuticals (SYRS) United States $0.458B 0.00
Starpharma Holdings (SPHRY) Australia $0.457B 0.00
Avid Bioservices (CDMO) United States $0.449B 0.00
AnaptysBio (ANAB) United States $0.439B 0.00
Pfenex (PFNX) United States $0.437B 0.00
Athersys (ATHX) United States $0.430B 0.00
IBio (IBIO) United States $0.429B 0.00
Sutro Biopharma (STRO) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
Fortress Biotech (FBIO) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.414B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
BioDelivery Sciences (BDSI) United States $0.411B 29.07
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Kamada (KMDA) Israel $0.390B 18.66
PDL BioPharma (PDLI) United States $0.380B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 8.83
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.351B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.351B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.349B 0.00
Trevena (TRVN) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Precision BioSciences (DTIL) United States $0.311B 0.00
Menlo Therapeutics (VYNE) United States $0.307B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
Innate Pharma S.A (IPHA) France $0.302B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Cyclerion Therapeutics (CYCN) United States $0.285B 0.00
Prometic Life Sciences (LMNL) Canada $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.281B 0.00
Selecta Biosciences (SELB) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
NextCure (NXTC) United States $0.263B 0.00
Arbutus Biopharma (ABUS) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.224B 0.00
TELA Bio (TELA) United States $0.222B 0.00
Dyadic (DYAI) United States $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.219B 0.00
XOMA (XOMA) United States $0.218B 0.00
DBV Technologies S.A (DBVT) France $0.214B 0.00
Spero Therapeutics (SPRO) United States $0.214B 0.00
Kindred Biosciences (KIN) United States $0.208B 0.00
Cerecor (CERC) United States $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Checkpoint Therapeutics (CKPT) United States $0.204B 0.00
Cardiff Oncology (CRDF) United States $0.202B 0.00
Theratechnologies (THTX) Canada $0.201B 0.00
Biofrontera AG (BFRA) Germany $0.200B 0.00
Eton Pharmaceuticals (ETON) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Exicure (XCUR) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.174B 8.10
Aytu Bioscience (AYTU) United States $0.166B 0.00
AquaBounty Technologies (AQB) United States $0.166B 0.00
Aptinyx (APTX) United States $0.163B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.155B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.148B 0.00
Five Prime Therapeutics (FPRX) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.147B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.147B 0.00
CorMedix Inc (CRMD) United States $0.144B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Cidara Therapeutics (CDTX) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.134B 0.00
Gritstone Oncology (GRTS) United States $0.125B 0.00
Palatin Technologies (PTN) United States $0.123B 3.16
Lumos Pharma (LUMO) United States $0.121B 0.00
Strongbridge Biopharma (SBBP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.118B 6.02
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Vaccinex (VCNX) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.112B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.106B 0.00
ARAVIVE, INC (ARAV) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.098B 0.00
Idera Pharmaceuticals (IDRA) United States $0.094B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Bionano Genomics (BNGO) United States $0.085B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
AmpliPhi Biosciences (ARMP) United States $0.063B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Emmaus Life Sciences (EMMA) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 76.25
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Genetic Technologies (GENE) Australia $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.049B 0.00
Signal Genetics (MGEN) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
IMMURON (IMRN) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
Spherix (AIKI) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00